The Postoperative Impact of Co-morbidity in Colorectal Cancer Surgery.
- Author:
Hee Seok SUH
1
;
Kang Hong LEE
;
Hee Cheol KIM
;
Chang Sik YU
;
Jin Cheon KIM
Author Information
1. Hang-Sarang Coloproctology Clinic, Ansan, Korea.
- Publication Type:Original Article
- Keywords:
Comorbidity;
Complications;
Length of stay;
Colorectal neoplasms
- MeSH:
Asthma;
Cardiovascular Diseases;
Chronic Disease;
Colorectal Neoplasms*;
Comorbidity;
Diagnosis;
Humans;
Hypertension;
Ileus;
Kidney Failure, Chronic;
Length of Stay;
Lung Diseases, Obstructive;
Medical Records;
Postoperative Complications;
Prevalence;
Wounds and Injuries
- From:Journal of the Korean Society of Coloproctology
2003;19(5):299-306
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: Co-morbidity is the presence of co-existing or additional diseases during the initial diagnosis. It may be used as a prognostic indicator for the postoperative outcomes in most cancers, including colorectal cancers. The impact of respective co-morbidities in colorectal cancer surgeries were evaluated to identify their outcomes regarding complications and hospital stay. METHODS: The medical records of 2,242 colorectal cancer patients, who had had curative operations between Jan. 1997 and Dec. 2001, were reviewed to evaluate the prevalence of co-morbidities. All co-morbidities were adequately evaluated and managed preoperatively. RESULTS: Co-morbidities were observed in 789 out of the 2,242 (35.2%) patients. Hypertension was the most frequent (340, 15.2%), with diabetes (210, 9.4%) and cardiovascular diseases (124, 5.5%) following. Early stages (0~II) were more frequently associated with co-morbidities, compared to late stages (III~IV) (P<0.001). Hypertension and cerebrovascular diseases were significantly associated with postoperative complications (P<0.05). Postoperative complications occurred in 578 out of the 2242 (25.8%) patients: e.g., ileus (10.2%), voiding difficulty (4.4%), wound problems (4.3%), etc. Pulmonary complications occurred more often in patients with cerebrovascular diseases, hypertension, and asthma. Wound complications were observed in patients with hypertension, cerebrovascular diseases, chronic obstructive pulmonary disease, and chronic renal failure (P<0.05). Patients with more than one co-morbidity were closely associated with frequent postoperative co-mplications (P<0.05). However, comorbidities did not seem to affect the duration of the postoperative hospital stay. CONCLUSIONS: Postoperative complications frequently occur in colorectal cancer patients with specific co- morbidities, especially in those with more than one. An adequate management of the co-morbidities preoperatively leads to a good outcome.
